Fig. 1From: Dysregulation of CCAAT/enhancer binding protein-alpha (CEBPA) expression in the bone marrow of acute myeloid leukemia patientsa Comparative expression of CEBPA mRNA in AML patients and control group. b ROC analysis of CEBPA gene in AML patients compared to healthy control. c Association between CEBPA gene dysregulation and FLT3 mutationBack to article page